UY31864A - Derivados de urea hetericíclica y métodos de uso de los mismos-332 - Google Patents

Derivados de urea hetericíclica y métodos de uso de los mismos-332

Info

Publication number
UY31864A
UY31864A UY0001031864A UY31864A UY31864A UY 31864 A UY31864 A UY 31864A UY 0001031864 A UY0001031864 A UY 0001031864A UY 31864 A UY31864 A UY 31864A UY 31864 A UY31864 A UY 31864A
Authority
UY
Uruguay
Prior art keywords
hetericíclica
urea
derivatives
methods
same
Prior art date
Application number
UY0001031864A
Other languages
English (en)
Inventor
Hill Pamela
Sherer Brian
John Irvin Manchester
Allison Laura Choy
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40823415&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY31864(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of UY31864A publication Critical patent/UY31864A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/06—Peri-condensed systems

Abstract

Se describen compuestos de fórmula (I) y sus sales farmacéuticamente aceptables. También se describen procesos para su preparación, composiciones farmacéuticas que los contienen, su uso como medicamentos y su uso en el tratamiento de infecciones bacterianas.
UY0001031864A 2008-06-04 2009-06-03 Derivados de urea hetericíclica y métodos de uso de los mismos-332 UY31864A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5873608P 2008-06-04 2008-06-04

Publications (1)

Publication Number Publication Date
UY31864A true UY31864A (es) 2010-01-29

Family

ID=40823415

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001031864A UY31864A (es) 2008-06-04 2009-06-03 Derivados de urea hetericíclica y métodos de uso de los mismos-332

Country Status (23)

Country Link
US (1) US8283361B2 (es)
EP (1) EP2300463A1 (es)
JP (1) JP2011522026A (es)
KR (1) KR20110014710A (es)
CN (1) CN102105469A (es)
AR (1) AR072045A1 (es)
AU (1) AU2009254930A1 (es)
BR (1) BRPI0915471A2 (es)
CA (1) CA2725568A1 (es)
CL (1) CL2009001349A1 (es)
CO (1) CO6382176A2 (es)
CR (1) CR11825A (es)
DO (1) DOP2010000373A (es)
EA (1) EA201001858A1 (es)
EC (1) ECSP10010664A (es)
IL (1) IL209503A0 (es)
MX (1) MX2010013310A (es)
PE (1) PE20100155A1 (es)
SV (1) SV2010003752A (es)
TW (1) TW201000475A (es)
UY (1) UY31864A (es)
WO (1) WO2009147433A1 (es)
ZA (1) ZA201008610B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100130737A1 (en) * 2005-02-18 2010-05-27 Takeda Pharmaceutical Company Limited Regulating Agent of GPR34 Receptor Function
TW201102065A (en) * 2009-05-29 2011-01-16 Astrazeneca Ab Heterocyclic urea derivatives and methods of use thereof
WO2010142978A1 (en) * 2009-06-08 2010-12-16 Astrazeneca Ab Heterocyclic urea derivatives and methods of use thereof
MX2012010666A (es) 2010-03-31 2012-10-05 Actelion Pharmaceuticals Ltd Derivados de isoquinolin-3-ilurea antibacterianos.
AR088729A1 (es) 2011-03-29 2014-07-02 Actelion Pharmaceuticals Ltd Derivados de 3-ureidoisoquinolin-8-ilo y una composicion farmaceutica
CN105067814A (zh) * 2015-07-24 2015-11-18 中国科学院成都生物研究所 解旋酶水解atp活性测定方法
WO2018048882A1 (en) 2016-09-06 2018-03-15 The Research Foundation For The State University Of New York Positron imaging tomography imaging agent composition and method for bacterial infection
WO2018074880A2 (ko) * 2016-10-20 2018-04-26 한국화학연구원 퀴놀린 4-온 유도체 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 포함하는 폐렴의 예방 또는 치료용 약학적 조성물
WO2018174288A1 (ja) 2017-03-24 2018-09-27 大正製薬株式会社 ２（１ｈ）－キノリノン誘導体
CN111808089B (zh) * 2019-04-10 2023-04-11 四川大学华西医院 一种治疗糖尿病的药物依格列净或其衍生物的制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993000342A1 (en) 1991-06-21 1993-01-07 Boehringer Mannheim Italia S.P.A. 2-amino-4-aryl-thiazoles with antiasthmatic and anti-inflammatory activities on the respiratory tract
MXPA03005298A (es) 2000-12-15 2003-10-06 Vertex Pharma Inhibidores de girasa y usos de los mismos.
AR042956A1 (es) 2003-01-31 2005-07-13 Vertex Pharma Inhibidores de girasa y usos de los mismos
WO2006092599A2 (en) * 2005-03-04 2006-09-08 Astrazeneca Ab Pyrrole derivatives as dna gyrase and topoisomerase inhibitors
US8022816B2 (en) 2005-03-21 2011-09-20 Vela Systems, Inc. System and method for field management using radio frequency tags
US7569907B2 (en) 2005-03-28 2009-08-04 Cooper Technologies Company Hybrid chip fuse assembly having wire leads and fabrication method therefor
ATE435489T1 (de) 2005-04-13 2009-07-15 Koninkl Philips Electronics Nv Modifizierte dct transformation zur basisband- phasenmodulation von einem mp3 bitstream, und einfügung von wasserzeichen.
WO2007071965A2 (en) * 2005-12-23 2007-06-28 Astrazeneca Ab Antibacterial pyrrolopyridines, pyrrolopyrimidines, and pyrroloazepines
DE102006012337B3 (de) 2006-03-17 2007-11-29 Amphenol-Tuchel Electronics Gmbh Elektrischer Steckverbinder
CN101627038A (zh) * 2006-12-04 2010-01-13 阿斯利康(瑞典)有限公司 抗菌多环脲化合物
CN201038186Y (zh) 2007-03-08 2008-03-19 鹤山丽得电子实业有限公司 一种大功率led
TW200940537A (en) * 2008-02-26 2009-10-01 Astrazeneca Ab Heterocyclic urea derivatives and methods of use thereof
WO2009110688A2 (ko) 2008-03-06 2009-09-11 Jang Gum Sik 태양광 발전 장치
WO2010142978A1 (en) * 2009-06-08 2010-12-16 Astrazeneca Ab Heterocyclic urea derivatives and methods of use thereof

Also Published As

Publication number Publication date
AU2009254930A1 (en) 2009-12-10
CA2725568A1 (en) 2009-12-10
CN102105469A (zh) 2011-06-22
DOP2010000373A (es) 2011-01-15
CR11825A (es) 2011-02-04
ZA201008610B (en) 2012-08-29
IL209503A0 (en) 2011-01-31
SV2010003752A (es) 2011-04-14
AR072045A1 (es) 2010-08-04
CO6382176A2 (es) 2012-02-15
MX2010013310A (es) 2011-03-01
KR20110014710A (ko) 2011-02-11
JP2011522026A (ja) 2011-07-28
EP2300463A1 (en) 2011-03-30
US8283361B2 (en) 2012-10-09
TW201000475A (en) 2010-01-01
PE20100155A1 (es) 2010-03-25
WO2009147433A1 (en) 2009-12-10
ECSP10010664A (es) 2011-01-31
US20100190745A1 (en) 2010-07-29
BRPI0915471A2 (pt) 2017-06-27
CL2009001349A1 (es) 2010-12-31
EA201001858A1 (ru) 2011-08-30

Similar Documents

Publication Publication Date Title
DOP2010000259A (es) Derivados heterociclicos de urea y metodos de uso de los mismos-211
UY32158A (es) Derivados heterociclicos y metodos de uso de los mismos
UY30759A1 (es) Compuestos quimicos
UY32315A (es) Compuestos de piperidina y usos de los mismo-596
UY31864A (es) Derivados de urea hetericíclica y métodos de uso de los mismos-332
UY31860A (es) Piridinas de tiazolo como inhibidoras de la adn girasa
UY31141A1 (es) Compuestos de piperidina y sus usos
DOP2010000374A (es) Derivados heterociclicos de la urea y sus metodos de empleo
UY32674A (es) Derivados heterociclicos de la urea y sus metodos de empleo
UY32203A (es) Amino pirimidinas y su uso en terapia
UY30544A1 (es) Compuestos de pirrolo-piperidina y sales farmacéuticametne aceptables de los mismos, procesos de fabricacion, composiciones y aplicaciones
UY32856A (es) Derivados heterocíclicos de urea y métodos de uso de los mismos
CL2011000589A1 (es) Compuestos derivados de pirrolidin-2-carboxamida, inhibidores de la interaccion p53-mdm2; composicion farmaceutica que los comprende; y su uso en la preparacion de medicamentos utiles para el tratamiento del cancer.
UY31069A1 (es) Nuevos derivados de imidazoquinola, composiciones conteniendolos, proceso de preparacion y aplicaciones
CO6640270A2 (es) Morfolinopirimidad y su uso en terapia
UY31481A1 (es) Nuevos derivados de pirimidina, procesos de preparacion, composiciones farmacéuticas conteniéndolos y aplicaciones
NI201100130A (es) Derivados de pirimidin indol para el tratamiento de cáncer.
SV2010003451A (es) Derivados de pirimidina trisustituida para el tratamiento de enfermedades proliferativas
ECSP109856A (es) Derivados de oxadiazol y su uso como potenciadores de los receptores metabotrópicos de glutamato - 842
NI201000004A (es) Derivados de pirimidina trisustituida para el tratamiento de enfermedades proliferativas.
UY32694A (es) Derivados heterocíclicos de urea y métodos de uso de los mismos
UY32316A (es) Derivados de piperidina utiles en el tratamiento de infecciones bacterianas
CU20110108A7 (es) [4-(1-amino-etil)-ciclohexil]-metil-aminas como antibacterianos
UY31805A (es) Agonistas m1, composiciones farmacéuticas de los mismos, procesos para su preparacion y sus usos para el tratamiento del dolor
CU20100172A7 (es) Derivados heterocíclicos de urea y métodos de uso de los mismos-211

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20181029